WFC
58
-2
PRU
47
-3
MMM
35
-5
MLM
35
-2
NWS
64
-9
PNC
48
-2
NEE
39
-3
MHK
25
-2
TAP
51
-2
PX
53
-5
EXPE
83
-5
GOOGL
59
-5
NVDA
52
-4
HOG
26
-3
BAX
39
-2
BK
61
-4
KHC
15
2
VFC
54
-4
JCI
41
-3
NI
67
-3
WFC
58
-2
PRU
47
-3
MMM
35
-5
MLM
35
-2
NWS
64
-9
PNC
48
-2
NEE
39
-3
MHK
25
-2
TAP
51
-2
PX
53
-5
EXPE
83
-5
GOOGL
59
-5
NVDA
52
-4
HOG
26
-3
BAX
39
-2
BK
61
-4
KHC
15
2
VFC
54
-4
JCI
41
-3
NI
67
-3
Financhill
Back

Nuveen Dow 30sm Dynamic Overwrite Fund Vs. Aligos Therapeutics Industry Stock Comparison

Sell
24

DIAX
Nuveen Dow 30sm Dynamic Overwrite Fund

Last Price:
$15.17
Seasonality Move:
-1.17%
Buy
62

ALGS
Aligos Therapeutics

Last Price:
$41.28
Seasonality Move:
-16.03%
Sell
24
Nuveen Dow 30sm Dynamic Overwrite Fund (DIAX) is a Sell

Is Nuveen Dow 30sm Dynamic Overwrite Fund a Buy, Sell or Hold?

  • The current Nuveen Dow 30sm Dynamic Overwrite Fund [DIAX] share price is $15.19. The Score for DIAX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • DIAX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $41.15. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DIAX Stock Price Chart

What is Nuveen Dow 30sm Dynamic Overwrite Fund's stock price today?

  • The Nuveen Dow 30sm Dynamic Overwrite Fund share price today is $15.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DIAX is experiencing slight buying pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $41.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.

DIAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 48.16 Sell
Chaikin Money Flow: 7623 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.06 - 15.76) Sell
Bollinger Bands (100): (14.45 - 15.35) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.69 Buy
Relative Strength Index (14 RSI): 73.75 Buy
Chaikin Money Flow: -154898 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.72 - 37.64) Buy
Bollinger Bands (100): (6.81 - 25.85) Buy

DIAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15 Buy
20-day SMA: 15.37 Sell
50-day SMA: 15.21 Sell
200-day SMA: 14.5 Buy
8-day EMA: 15.14 Buy
20-day EMA: 15.23 Sell
50-day EMA: 15.18 Buy
200-day EMA: 14.69 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.54 Buy
20-day SMA: 33.12 Buy
50-day SMA: 21.28 Buy
200-day SMA: 16.61 Buy
8-day EMA: 38.79 Buy
20-day EMA: 33.47 Buy
50-day EMA: 25.09 Buy
200-day EMA: 18.34 Buy

Nuveen Dow 30sm Dynamic Overwrite Fund Earnings Growth & DIAX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Nuveen Dow 30sm Dynamic Overwrite Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):